MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-17-0059936
Leodius Pharmaceuticals Private Limited
Leodius Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹26.71 Lakh
▼ 3% YoY
Net profit · FY 2025
₹40,505
Net margin 1.5%
EBITDA · FY 2025
₹60,275
EBITDA margin 2.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Leodius Pharmaceuticals Private Limited
Data last updated:
Leodius Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 February 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2022PTC377136. Its GSTIN is 27AAECL9276A1ZF (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Neeraj Prabhan Yadav and Laxmi Neeraj Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No.61 Ground Floor Pavitra Smith S No.23&24 Hissa No.1 2&4 Vasai East, Thane, Maharashtra, India – 401208.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.71 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹40,505 (net margin 1.5%) and EBITDA of ₹60,275 (EBITDA margin 2.3%).
Leodius Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0059936).
Company Details of Leodius Pharmaceuticals Private Limited
CIN U24239MH2022PTC377136
Registration Number 377136
Incorporation Date 18 February 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-17-0059936
Recognitions & Rankings of Leodius Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No.61 Ground Floor Pavitra Smith S No.23&24 Hissa No.1 2&4 Vasai East, Thane, Maharashtra, India – 401208
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Leodius Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity
The main business activity of Leodius Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Leodius Pharmaceuticals Private Limited
FY 2025 filings availableLeodius Pharmaceuticals Private Limited reported revenue of ₹26.71 Lakh (down 3% YoY) for FY 2025.
Revenue · FY 2025
₹26.71 Lakh ▼ 3%
Net profit · FY 2025
₹40,505 margin 1.5%
EBITDA · FY 2025
₹60,275 margin 2.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 3%
EBITDA CAGR growth
1 year
▲ 2%
Revenue fell 3% in the latest year. EBITDA rose 2% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2021-22 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹60,275 | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹40,505 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2021-22 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.3% | |
| Net Profit Margin | 1.5% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2021-22 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Leodius Pharmaceuticals are in the company report.
: available in the company report
Board of Directors of Leodius Pharmaceuticals Private Limited
Leodius Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeraj Prabhan Yadav | Director | 18 Feb 2022 | 4 Years 8 Months | Current |
| Laxmi Neeraj Yadav | Director | 30 Jul 2025 | 1 Years 2 Months | Current |
Peer Comparison
Leodius Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maxiss Pharmaceuticals Private Limited | ₹26.77 Lakh (FY 2023) | •••• | •••• | 291.0% | •••• | Ahmedabad, Gujarat, India |
| Leodius Pharmaceuticals Private Limited this company | ₹26.71 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Thane, Maharashtra, India |
| Vertis Pharmaceuticals Private Limited | ₹26.71 Lakh (FY 2020) | •••• | •••• | -4.0% | •••• | Panipat, Haryana, India |
| Biomedic Pharmaceuticals Private Limited | ₹26.7 Lakh (FY 2024) | •••• | •••• | 24.0% | •••• | Hyderabad, Telangana, India |
Peers are the companies nearest to Leodius Pharmaceuticals by revenue, above and below it, in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Leodius Pharmaceuticals Private Limited is audited by Ishrat Shaikh for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Ishrat Shaikh | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Leodius Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Leodius Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 05, 2024.
Active EPFO establishments
1
: available in the company report
Recent Activity
Leodius Pharmaceuticals Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Sunil Rammanohar Jaiswal ceased to be Director on 05 Aug 2025.
AGM
Leodius Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Sunil Rammanohar Jaiswal ceased to be Director.
Appointed
Laxmi Neeraj Yadav was appointed as Director.
Filing
Leodius Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Neeraj Prabhan Yadav was appointed as Director.
Appointed
Sunil Rammanohar Jaiswal was appointed as Director.
Incorporation
18 Feb 2022
Leodius Pharmaceuticals Private Limited was registered on 18 Feb 2022 with Roc Mumbai Ii & aged 4 years 8 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Leodius Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECL9276A1ZF | Maharashtra | Active | 03 Apr 2022 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Leodius Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 February 2022 (4+ years old) and is registered under CIN U24239MH2022PTC377136.
Leodius Pharmaceuticals has 2 current directors:
- Neeraj Prabhan Yadav - Director
- Laxmi Neeraj Yadav - Director
The latest financial statements of Leodius Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Leodius Pharmaceuticals is 27AAECL9276A1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Leodius Pharmaceuticals is U24239MH2022PTC377136. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Leodius Pharmaceuticals was incorporated on 18 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Leodius Pharmaceuticals by revenue are Maxiss Pharmaceuticals Private Limited, Vertis Pharmaceuticals Private Limited, Biomedic Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Sunil Rammanohar Jaiswal ceased to be Director on 05 Aug 2025. Laxmi Neeraj Yadav was appointed as Director on 30 Jul 2025. Neeraj Prabhan Yadav was appointed as Director on 18 Feb 2022. Leodius Pharmaceuticals has 4 board changes on record in total.
Yes, Leodius Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-17-0059936).
The registered office of Leodius Pharmaceuticals is at Shop No.61 Ground Floor Pavitra Smith S No.23&24 Hissa No.1 2&4 Vasai East, Thane, Maharashtra, India – 401208.
Leodius Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.